In recognition of National Diabetes Awareness, The Daily Transcript looks at how local companies are finding ways to combat diabetes. Contact us at email@example.com to get more involved.
BRUSSELS, BELGIUM -- One in 10 of the world's population will have diabetes by 2035, according to the International Diabetes Federation. The latest edition of IDF Diabetes Atlas, published Thursday on World Diabetes Day, estimates that people living with diabetes will surge from 382 million to 592 million people by 2035, many in low- and middle-income countries and the majority under age 60. This surge will form the backdrop of the World Diabetes Congress in Melbourne, Australia, this December.
Shares of Tandem Diabetes Care Inc. soared in their first day of trading as a public company.
Shares of DexCom jumped Thursday after the medical device maker's third-quarter sales surpassed Wall Street forecasts.
Oct. 23 (Bloomberg) -- Eli Lilly & Co., which may introduce five new drugs next year, reported third-quarter profit that beat analysts’ estimates on cost cuts and higher sales of diabetes products.
San Diego-based Elcelyx Therapeutics has completed a 12-week Phase 2b study of NewMet, a delayed-release formulation of metformin for the treatment of patients with type 2 diabetes.
Kaiser Permanente San Diego has earned The Joint Commission's Gold Seal of Approval for its inpatient diabetes care program by demonstrating compliance with The Joint Commission's national standards for health care quality and safety in disease-specific care.
NEW YORK (AP) -- Shares of Lexicon Pharmaceuticals surged Tuesday after the company reported successful trial results for a diabetes drug intended for patients with kidney impairment.
Sept. 27 (Bloomberg) -- Medtronic Inc. the world’s largest maker of heart-rhythm devices, won U.S. regulatory approval for the first artificial pancreas that shuts itself off when a patient’s blood sugar levels get dangerously low.
Sept. 4 (Bloomberg) -- China’s diabetes epidemic is worse than previously estimated -- much worse.
Genalyte Inc. has announced it is collaborating with the Barbara Davis Center for Childhood Diabetes at the University of Colorado School of Medicine to further develop and test multiplexed antigen panels for the early detection of Type 1 diabetes.
VALENCIA, Calif. (AP) -- Drug developer MannKind says its inhaled insulin Afrezza met the main goals behind two late-stage studies involving patients with two types of diabetes.
WASHINGTON (AP) -- The Food and Drug Administration is cracking down on more than a dozen companies that market illegal treatments for diabetes, ranging from bogus dietary supplements to prescription drugs sold online without a prescription.
Isis Pharmaceuticals Inc. (Nasdaq: ISIS) climbed the most in more than 11 years on data showing the company’s experimental drug helped bring down diabetes patients’ triglyceride levels, an important measure of heart health.
June 12 (Bloomberg) -- Merck & Co., Novo Nordisk A/S and other makers of popular treatments for diabetes may be asked to collect more data on a potential cancer link even as they try to reassure regulators this week of the drugs’ safety.
NEW YORK (AP) -- Merck & Co. said Monday it will work with Pfizer Inc. to develop a new combination pill designed to treat Type 2 diabetes.
Employees of Takeda California, a drug discovery research company, traded their lab coats for bicycles on April 12 for the company's annual “Tour de Takeda” bike ride and walk to raise funds for the American Diabetes Association. Takeda California donated $5 for every mile covered by the bikers and walkers, and raised $13,400 after 2,680 miles, according to a release.
WASHINGTON (AP) -- The Food and Drug Administration is looking into evidence that a group of new diabetes drugs can increase the risk of pancreatitis and other problems.
San Diego-based Genalyte Inc. won a Small Business Innovation Research (SBIR) grant to develop multiplexed diagnostic assays for the early detection and monitoring of type 1 diabetes.
A study led by researchers from the University of California, San Diego School of Medicine has found a correlation between vitamin D3 serum levels and subsequent incidence of Type 1 diabetes.
During American Diabetes Month, Palomar Health diabetes experts are drawing attention to some shocking statistics about the disease and providing information to people who are concerned about diabetes-related amputations.
The number of people living with diabetes is soaring in the United States, as 18 states had at least a doubling in those with the illness since 1995, a government survey found.
Stephen S. was shocked when he heard the news: He had type 2 diabetes.
During American Diabetes Month this November, the American Diabetes Association will launch a socially-focused initiative, "A Day in the Life of Diabetes," to demonstrate the increasing impact diabetes has on families and communities nationwide.
The heart risks with Novo Nordisk A/S’s once-a-day insulin Tresiba are probably not of enough concern to block approval of the medicine, the majority of an advisory panel to the U.S. Food and Drug Administration said.
COPENHAGEN, Denmark (AP) -- Danish pharmaceutical company Novo Nordisk A/S (NYSE: NVO) says its net profit grew by 35 percent in the third quarter of 2012, chiefly spurred by strong sales of its diabetes drugs.
INDIANAPOLIS (AP) -- Drugmaker Eli Lilly says it is planning a multi-million dollar expansion of its manufacturing operations to make cartridges that deliver insulin to patients.
In a new study published in "Aging Cell," researchers at the Salk Institute for Biological Studies show, for the first time, that diabetes enhances the development of aging features that may underlie early pathological events in Alzheimer's.
ViaCyte Inc. scored a $10.1 million award from the California Institute for Regenerative Medicine (CIRM) to continue working on a transformative cell therapy that has the potential to essentially cure patients with type 1 diabetes.
San Diego-based West Health Investment Fund, focused on lowering health care costs, has announced it participated in the recent venture financings of GlySens Inc. and RxAnte Inc., two startup companies with technologies aimed at lowering the cost of health care.
Researchers at the La Jolla Institute for Allergy & Immunology have created the first cellular movies showing the destruction underlying type 1 diabetes in real-time in mouse models.
Virgil Rochester of Escondido is a World War II veteran, a retired military and civilian lawyer and a longtime diabetic.
Eating a daily additional amount of Omega-3 fatty acids may help protect older people with diabetes who have experienced a heart attack, according to a study being published in the December issue of Diabetes Care.
With companies like Amylin Pharmaceuticals, ViaCyte Inc., DexCom and others, San Diego has earned a reputation as a leader in diabetes research. With a recent approval from the Food and Drug Administration, the industry can add Tandem Diabetes Care Inc. to the list of local leaders.
No culture or socioeconomic group is immune to diabetes, so the San Diego branch of the American Diabetes Association has programs designed to reach everyone from the local chapters of major corporations, to underserved Latino communities.
Halozyme Therapeutics Inc. is hoping to make life a little more predictable for diabetics who use a pump to administer their daily insulin.
The American Diabetes Association in early November announced a request for applications to research the relationship between the brain and diabetes as well as upcoming efforts to better understand the consequences of hypoglycemia in people with diabetes.
GENEVA -- The International Diabetes Federation predicts that one in 10 adults could have diabetes by 2030, according to their latest statistics.
Editor's note: In observance of Diabetes Awareness Month, The Daily Transcript will feature weekly stories highlighting the efforts under way in San Diego to help in the fight against diabetes. The following article is another in the series: